Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05589051 · ClinicalTrials.gov registry record · NA
Effect of Alpha Hope Dietary Supplement on Health and Cognitive Performance
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05589051 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 14 participants.
The verdict
NCT05589051, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of the present research study is to evaluate the claims about the supplement influencing cognitive function that may impact performance on cognitive task and related biochemical measures. The synergistic administration of Pyrroloquinoline Quinone and molecular Hydrogen (in the form of Alpha Hope) will be evaluated in adults without a diagnosis of disease (i.e., otherwise healthy adults-the population the supplement is marketed to) on certain biochemical markers, subject's self-assessed wellness, and functional measurements determined via computer tests.
Interventions
- DIETARY_SUPPLEMENT Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2022-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05589051
The ClinicalTrials.gov registry entry for NCT05589051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Drink is the first listed.
NCT05589051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05589051 about?
NCT05589051 is a clinical study titled "Effect of Alpha Hope Dietary Supplement on Health and Cognitive Performance". The purpose of the present research study is to evaluate the claims about the supplement influencing cognitive function that may impact performance on cognitive task and related biochemical measures. The synergistic administration of Pyrroloquinoline Quinone and molecular Hydrogen (in the form of Al...
What is the current status of trial NCT05589051?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-03-21. Estimated completion is 2022-11-10.
What interventions are being tested in trial NCT05589051?
The interventions under investigation include: Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05589051?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.